Response evaluation following neoadjuvant treatment of pancreatic cancer patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

370

HTML

2423

Tables (1-2)

144

Sum=2937

Publishing Process of This Article

Item

Count

Browse

842

Download

924

Sum=1766

Feb 27, 2013 (publication date) through May 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Field Of Vision

World J Gastrointest Surg. Feb 27, 2013; 5(2): 12-15
Published online Feb 27, 2013. doi: 10.4240/wjgs.v5.i2.12

Table 2 Some questions towards the aim and the clinical meaning of neoadjuvant treatment in pancreatic cancer

How reliable is traditional imaging assessment of resectability?

Were these tumors resectable even before (radio) chemotherapy administration?

If so, was (radio) chemotherapy useful or did it only delay surgery?

Which exactly is the target of neoadjuvant treatment?

Citation: Tosolini C, Michalski CW, Kleeff J. Response evaluation following neoadjuvant treatment of pancreatic cancer patients. World J Gastrointest Surg 2013; 5(2): 12-15
URL: https://www.wjgnet.com/1948-9366/full/v5/i2/12.htm
DOI: https://dx.doi.org/10.4240/wjgs.v5.i2.12